Literature DB >> 8786015

Very low density lipoprotein subfraction abnormalities in IDDM patients: any effect of blood glucose control?

L Patti1, L Di Marino, A Maffettone, G Romano, G Annuzzi, G Riccardi, A A Rivellese.   

Abstract

Normolipidaemic insulin-dependent diabetic (IDDM) patients are characterized by an increase in the smaller VLDL particles, considered to be the most atherogenic. Since blood glucose control is one of the main regulators of lipid metabolism in diabetic patients, it could influence the shift in the distribution of VLDL subfractions towards smaller particles. To evaluate this possibility, VLDL subfractions, post-heparin lipoprotein lipase and hepatic lipase activities have been evaluated in male IDDM patients with either unsatisfactory blood glucose control (group 1, HbA1c > 8%, n = 18) or good blood glucose control (group 2, HbA1c < 8%, n = 16) and in 16 normoglycaemic individuals. The three groups were comparable for sex, age, body mass index, and plasma lipid levels. Three VLDL subfractions (large, Svedberg flotation unit (Sf) 175-400; intermediate, Sf 100-175; small, Sf 20-100) were separated by density gradient ultracentrifugation and analysed for cholesterol, triglyceride, and phospholipid levels. When compared to control subjects both groups of IDDM patients showed a clear shift in VLDL subfraction distribution with a significant increase in the proportion of small VLDL (group 1; 49 +/- 2%; p < 0.005; group 2: 51 +/- 3%, p < 0.01; control subjects 40 +/- 2%) (mean +/- SEM) in relation to total VLDL. By contrast, the absolute lipid concentration of small VLDL was higher only in group 1, compared to control subjects (35 +/- 4 vs 27 +/- 3 mg/dl, p = 0.05). Post-heparin hepatic lipase activity was significantly reduced in both IDDM groups (group 1: 254 +/- 19 mU/ml, p < 0.05; group 2: 202 +/- 19 mU/ml, p < 0.005; control subjects 317 +/- 31 mU/ml). In conclusion, normolipidaemic IDDM patients show an increase in the smallest VLDL, whatever their degree of blood glucose control. However, this abnormality may be clinically relevant only in patients with unsatisfactory blood glucose control, since absolute lipid concentration of these potentially atherogenic particles is only increased in this group.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8786015     DOI: 10.1007/bf00400602

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  Letter: Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation.

Authors:  G M Kostner
Journal:  Clin Chem       Date:  1976-05       Impact factor: 8.327

2.  Lipoprotein fractionation.

Authors:  K Carlson
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1973

3.  The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type I diabetes mellitus.

Authors:  A O Pietri; F L Dunn; S M Grundy; P Raskin
Journal:  Diabetes       Date:  1983-01       Impact factor: 9.461

4.  Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects.

Authors:  R W James; D Pometta
Journal:  Diabetes       Date:  1990-10       Impact factor: 9.461

5.  Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.

Authors:  M R Taskinen; C J Packard; J Shepherd
Journal:  Diabetes       Date:  1990-09       Impact factor: 9.461

6.  Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.

Authors:  E Manzato; A Zambon; S Zambon; R Nosadini; A Doria; R Marin; G Crepaldi
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

Review 7.  Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus.

Authors:  M R Taskinen
Journal:  Diabetes       Date:  1992-10       Impact factor: 9.461

8.  Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus.

Authors:  A S Krolewski; E J Kosinski; J H Warram; O S Leland; E J Busick; A C Asmal; L I Rand; A R Christlieb; R F Bradley; C R Kahn
Journal:  Am J Cardiol       Date:  1987-04-01       Impact factor: 2.778

9.  Cholesteryl ester synthesis in macrophages: stimulation by beta-very low density lipoproteins from cholesterol-fed animals of several species.

Authors:  R W Mahley; T L Innerarity; M S Brown; Y K Ho; J L Goldstein
Journal:  J Lipid Res       Date:  1980-11       Impact factor: 5.922

10.  Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.

Authors:  G Ruotolo; M Parlavecchia; M R Taskinen; G Galimberti; A Zoppo; N A Le; F Ragogna; P Micossi; G Pozza
Journal:  Diabetes Care       Date:  1994-01       Impact factor: 19.112

View more
  3 in total

1.  Relationship between lipid profiles and kidney function in patients with type 1 diabetes.

Authors:  N Tolonen; C Forsblom; L Thorn; J Wadén; M Rosengård-Bärlund; M Saraheimo; O Heikkilä; K Pettersson-Fernholm; M-R Taskinen; P-H Groop
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

2.  Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy.

Authors:  Laura Brugnara; Roger Mallol; Josep Ribalta; Maria Vinaixa; Serafín Murillo; Teresa Casserras; Montse Guardiola; Joan Carles Vallvé; Susana G Kalko; Xavier Correig; Anna Novials
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

3.  Evaluation of HbA1C and serum levels of vitamin D in diabetic patients.

Authors:  Samiramiss Ghavam; Mohammad Reza Hafezi Ahmadi; Ali Davar Panah; Behrang Kazeminezhad
Journal:  J Family Med Prim Care       Date:  2018 Nov-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.